 DIAPRESAN D
|
Montpellier
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.rec.x30 | $34.868,62 | (14/02/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $16.868,78 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $15.468,68 |
|
|
|
|
| 160/25 mg comp.rec.x30 | $43.093,89 | (14/02/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $19.547,03 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $18.838,57 |
|
|
|
|
| 320/12.5 mg comp.rec.x30 | $45.548,68 | (14/02/26) |
| PAMI |
|
| AF $18.469,44 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $25.063,23 AF $20.485,45 |
|
|
|
|
| 320/25 mg comp.rec.x30 | $45.826,82 | (14/02/26) |
|
|
|
| 80/12.5 mg comp.rec.x 30 | $30.037,15 | (14/02/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $13.106,10 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $12.278,15 |
|
|
|
|
| |
